Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

by Engesæter, Birgit, Engebraaten, Olav, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Published 2012

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening

by Hashim, Dana, Engesæter, Birgit, Baadstrand Skare, Gry, Castle, Philip E., Bjørge, Tone, Tropé, Ameli, Nygård, Mari
Published in Br J Cancer (2020)

hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma

by Fleten, Karianne G, Flørenes, Vivi Ann, Prasmickaite, Lina, Hill, Oliver, Sykora, Jaromir, Mælandsmo, Gunhild M, Engesæter, Birgit
Published in Cell Death Discov (2016)

Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma

by Prasmickaite, Lina, Engesæter, Birgit Ø., Skrbo, Nirma, Hellenes, Tina, Kristian, Alexandr, Oliver, Nina K., Suo, Zhenhe, Mælandsmo, Gunhild M.
Published 2010

Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention

by Lönnberg, Stefan, Andreassen, Trude, Engesæter, Birgit, Lilleng, Rune, Kleven, Cecilia, Skare, Annelie, Johansson, Karin, Fredheim, Christina Stangeland, Tropé, Ameli
Published in BMJ Open (2016)

Psychological effect of cervical cancer screening when changing primary screening method from cytology to high‐risk human papilloma virus testing

by Andreassen, Trude, Hansen, Bo T., Engesæter, Birgit, Hashim, Dana, Støer, Nathalie C., Tropé, Ameli, Moen, Kåre, Ursin, Giske, Weiderpass, Elisabete
Published in Int J Cancer (2019)

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma

by Magnussen, Gry Irene, Emilsen, Elisabeth, Giller Fleten, Karianne, Engesæter, Birgit, Nähse-Kumpf, Viola, Fjær, Roar, Slipicevic, Ana, Flørenes, Vivi Ann
Published in BMC Cancer (2015)

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors

by Seip, Kotryna, Fleten, Karianne G., Barkovskaya, Anna, Nygaard, Vigdis, Haugen, Mads H., Engesæter, Birgit Ø., Mælandsmo, Gunhild M., Prasmickaite, Lina
Published in Oncotarget (2016)

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

by Slipicevic, Ana, Øy, Geir Frode, Rosnes, Anne Katrine Ree, Stakkestad, Øystein, Emilsen, Elisabeth, Engesæter, Birgit, Mælandsmo, Gunhild M., Flørenes, Vivi Ann
Published 2013

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study

by Engesæter, Birgit, van Diermen Hidle, Bianca, Hansen, Mona, Moltu, Pia, Staby, Kjersti Mangseth, Borchgrevink-Persen, Siri, Vintermyr, Olav K., Lönnberg, Stefan, Nygård, Mari, Janssen, Emiel A. M., Castle, Philip E., Christiansen, Irene Kraus
Published in BMC Infect Dis (2016)